Jennifer Fountain Connolly

Of Counsel
Washington, D.C. Office

Ms. Connolly is of counsel at HBSS and operates the firm’s Washington, D.C. office. Her practice focuses on qui tam litigation, pharmaceutical pricing fraud cases and antitrust class actions. She has litigated complex class actions and qui tam litigation in federal and state courts across the country.

Ms. Connolly had a significant role in litigation against McKesson Corporation that alleged the company engaged in a scheme that raised the prices of over 400 brand-name prescription drugs which resulted in a $350 million settlement and was followed by class actions and individual cases brought by public payors against McKesson for the same conduct. Ms. Connolly was also a key member of the HBSS-led team that successfully tried the AWP litigation against four pharmaceutical company defendants, obtaining a verdict that was subsequently affirmed in all respect by the First Circuit Court of Appeals.

Ms. Connolly has held leadership positions in several cases involving pricing fraud and anti-competitive conduct in the pharmaceutical industry. She is also currently working on multiple cases filed under the federal False Claims Act and state counterparts that are currently under seal.

Prior to joining HBSS in May 2010, Ms. Connolly was a partner at Wexler Wallace LLP. Before that, Ms. Connolly worked at a boutique complex litigation firm in Denver, Colorado and worked as an Assistant Attorney General in the Business Regulation Unit of the Colorado Attorney General’s office.

Notable Cases:

• McKesson Litigation
  Interim Co-lead counsel for indirect purchasers.
• AWP Litigation
  Member of HB-lead team that tried pharmaceutical pricing case against four pharmaceutical company defendants and was affirmed in all respects by the First Circuit Court of Appeals.
• Live Concert Antitrust Litigation
  Co-lead Counsel representing ticket buyers from 22 regions alleging Clear Channel damaged competition in the market for the promotion of rock concerts.